Triclosan

Triclosan

SCHEMBL29356111

Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

fabI

The experimentally established mechanism targets of Triclosan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 6/20 1.00
HPGD P15428 2/20 1.00
NR1I2 O75469 1/20 1.00
LMNA P02545 1/20 1.00
PGR P06401 1/20 1.00
HSP90AA1 P07900 1/20 1.00
ADORA3 P0DMS8 1/20 1.00
MAPT P10636 1/20 1.00
HSPA5 P11021 1/20 1.00
CBR1 P16152 1/20 1.00
TBXA2R P21731 1/20 1.00
SLC6A2 P23975 1/20 1.00
AGTR1 P30556 1/20 1.00
SLC6A3 Q01959 1/20 1.00
TSHR P16473 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triclosan SCHEMBL3269 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL526378 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL29354475 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL29367506 1.00 TTR (1.00) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8015104 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8975439 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL1146628 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL3895700 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL8055151 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR
Triclosan SCHEMBL434693 0.98 TTR (0.96) TTRHPGDNR1I2LMNAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-3836851-B1 ABRADABLE THERAPEUTIC COATINGS AND DEVICES INCLUDING SUCH COATINGS ETHICON INC (US) 2024-06-05 EP claimed
WO-2024028266-A1 A PRESERVATIVE COMPOSITION BRAIN Biotech AG (DE) 2024-02-08 WO claimed
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
WO-2026087780-A1 CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2026-04-30 WO disclosed
WO-2026087745-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-30 WO disclosed
US-12582753-B2 Systems and methods for forming an antimicrobial orthopedic implant DePuy Synthes Products, Inc. (US) 2026-03-24 US disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4705765-A2 BUCCAL CELL DIAGNOSIS OF RISK IN FAMILIAL ARRHYTHMIA SYNDROMES Beth Israel Deaconess Medical Center, Inc. (US) 2026-03-11 EP disclosed
US-12551247-B1 Bone anchors and surgical instruments with integrated guide tips DePuy Synthes Products, Inc. (US) 2026-02-17 US disclosed
US-11311318-B2 Bone anchor assemblies and methods with improved locking DePuy Synthes Products, Inc. (US) 2022-04-26 US disclosed
WO-2022079142-A1 LIQUID COMPOSITION FOR USE IN THE PREVENTION OR REDUCTION OF SKIN IRRITATION, ALLERGY AND/OR AN INFECTIOUS DISEASE MEDODERM GMBH (DE) 2022-04-21 WO disclosed
EP-3982910-A1 A COOLING PREPARATION Symrise AG (DE) 2022-04-20 EP disclosed
US-11298158-B2 Connectors for use in systems and methods for reducing the risk of proximal junctional kyphosis MEDOS INTERNATIONAL SARL (CH) 2022-04-12 US disclosed
US-20220071666-A1 BONE ANCHORS MEDOS INTERNATIONAL SARL (CH) 2022-03-10 US disclosed
US-20220055006-A1 PROCESS FOR PREPARING POLYAMIDE MICROCAPSULES FIRMENICH SA (CH) 2022-02-24 US disclosed
US-20220039835-A1 OFFSET RODS, OFFSET ROD CONNECTORS, AND RELATED METHODS MEDOS INT SARL (CH) 2022-02-10 US disclosed
US-20220039797-A1 ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALING CILAG GMBH INTERNATIONAL (CH) 2022-02-10 US disclosed
EP-3626190-B1 DEVICES FOR SPINAL SCREW INSERTION DEPUY SYNTHES PRODUCTS INC (US) 2022-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551247-B1 Bone anchors and surgical instruments with integrated guide tips TOE1, BMP2, SYVN1 TTR 1476/4885HPGD 4837/4885NR1I2 2241/4885
US-12582753-B2 Systems and methods for forming an antimicrobial orthopedic implant SPOUT1, CUTA, CAPG TTR 1684/4885HPGD 3956/4885NR1I2 2776/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 TTR 85/4885HPGD 3492/4885NR1I2 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.